Investigating how a specific RNA affects the survival of advanced breast cancer cells
Project 3: MANCR Mediates Epigenetic Mechanisms for Survival of Advanced Breast Cancer
['FUNDING_P01'] · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · NIH-11074071
This study is looking at a special molecule called MANCR that helps aggressive breast cancer cells survive, and by understanding how it works, the researchers hope to find new ways to treat patients with advanced breast cancer that doesn't respond to regular treatments.
Quick facts
| Phase | ['FUNDING_P01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE (nih funded) |
| Locations | 1 site (BURLINGTON, UNITED STATES) |
| Trial ID | NIH-11074071 on ClinicalTrials.gov |
What this research studies
This research focuses on a long non-coding RNA known as MANCR, which plays a crucial role in the survival of aggressive breast cancer cells. By examining how MANCR interacts with chromatin, the study aims to uncover the mechanisms that allow these cancer cells to thrive, particularly in cases that are resistant to standard treatments. The researchers will utilize advanced techniques to analyze chromatin organization and the effects of inhibiting MANCR, which could lead to new therapeutic strategies for patients with advanced breast cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with advanced or aggressive breast cancer, particularly those with triple-negative or tamoxifen-resistant forms.
Not a fit: Patients with early-stage breast cancer or those whose cancer is not aggressive may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that specifically target and kill aggressive breast cancer cells, improving patient outcomes.
How similar studies have performed: While the role of long non-coding RNAs in cancer is an emerging field, this specific approach targeting MANCR is relatively novel and has not been extensively tested in prior studies.
Where this research is happening
BURLINGTON, UNITED STATES
- UNIVERSITY OF VERMONT & ST AGRIC COLLEGE — BURLINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: STEIN, JANET L — UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
- Study coordinator: STEIN, JANET L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: advanced breast cancer, advanced stage breast cancer, aggressive breast cancer